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Diabetes mellitus is a chronic disease, and its management focuses on monitoring and lowering a patient’s glucose level to prevent 
further complications. By tracking the glucose-induced shift in the surface-enhanced Raman-scattering (SERS) emission of 
mercaptophenylboronic acid (MPBA), we have demonstrated fast and continuous glucose sensing in the physiologically relevant 
range from 0.1 to 30 mM and verified the underlying mechanism using numerical simulations. Bonding of glucose on MPBA 
suppresses the “breathing” mode of MPBA at 1071 cm-1 and energizes the “constrained-bending” mode at 1084 cm-1, causing the 
dominant peak to shift from 1071 cm-1 toward 1084 cm-1. The MPBA-glucose bonding is also reversible, allowing continuous tracking 
of ambient glucose concentrations, and the MPBA-coated substrates showed very stable performance over a 30-day period, making 
the approach promising for long-term continuous glucose monitoring. Using this Raman-mode constraining and miniaturized SERS 
implants, we also successfully demonstrated intraocular glucose measurements in six ex vivo rabbit eyes within ±0.5 mM of readings 
obtained using a commercial glucose sensor.
Diabetes is a global chronic disease with no cure,1 requiring 
frequent monitoring and active management of glucose levels 
to prevent complications and improve patient outcomes.2,3 
Presently, the glucose level in a body is commonly measured 
using disposable enzymatic sensors that meter changes in 
current generated by glucose oxidation in a small sample of 
blood.4,5 However, in addition to short shelf-lives due to the 
intrinsic instability of enzymes and dependence on 
environmental conditions, the major drawback has been the 
painful and inconvenient extraction of blood required for 
testing.6-9 Less painful approaches using microneedles for blood 
extraction or measuring glucose in sweat or the interstitial fluid 
of skin provide less accurate measurements due to the small 
sample size or the significantly lower glucose levels in 
interstitial fluid and sweat compared with blood.10-15 Non-
enzymatic electrochemical approaches have also been explored 
to overcome the instability of enzymes, however these 
approaches lack specificity for glucose,16 and the sensing 
electrodes develop surface fouling caused by glucose 
oxidation.16-18
Alternatively, optical approaches have been investigated for 
implementing minimally or non-invasive intensity-based 
glucose sensing,19-26 but their use in practical applications has 
been severely limited by their insufficient sensitivity and low 
repeatability19,20 (See Supporting Information). Raman 
spectroscopy is no exception because glucose naturally exhibits 
weak Raman signals due to its small Raman scattering cross-
section, measuring only 5.6×10-30 cm2/molecules/steradians or 
about 14 orders of magnitude smaller than fluorescence, and 
glucose Raman emission is easily overshadowed by strong 
background noises from the surrounding environment.25-27 To 
increase the Raman emission, researchers have employed 
nanostructure-based surface-enhanced Raman scattering 
(SERS), which amplifies weak Raman signals by a factor of 106 
- 108.28-32 Because glucose molecules do not possess chemical 
affinity for SERS-substrate materials such as gold or silver, 
researchers used decanethiol (DT), mercaptohexanol (MH), and 
bisboronic acid as SERS-linker molecules and reported glucose 
detection down to 1 mM.33-37 However, large linker molecules 
keep the glucose molecules away from the nearfield 
enhancement of the substrate surface and make it difficult to 
achieve more sensitive and consistent measurements.38-40 
Glucose concentration has also been estimated by detecting an 
increase in Raman emission of the linker molecule 
mercaptophenylboronic acid (MPBA) or comparing relative 
intensity changes between two adjacent peaks of MPBA when 
glucose molecules are attached to MPBA.40,41 The former 
approach showed little increase in Raman emission while the 
latter approach was valid only in a highly acidic environment 
with a pH level close to 1.40,41
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Here, we demonstrate quantitative, continuous, and rapid 
sensing of glucose at physiologically observed levels by 
tracking the shifts in the MPBA’s surface-enhanced Raman-
emission peaks. The peak shifts directly result from the bonding 
of glucose molecules onto the hydroxyl group of MPBA (Figure 
1a, b), and we designed the SERS substrates to provide a broad 
enhancement over the wavelength range of interest (Figure 2).40 
We also identified the underlying mechanism of the Raman-
peak shift caused by glucose bonding onto MPBA using 
numerical simulations (Figure 3) and experimental 
measurements. Bonding of glucose significantly influences 
elasticity of a MPBA molecule, which changes the molecular 
geometries and Raman-scattering cross sections of two “C-
ring” vibrational modes (Figure 3). When a glucose molecule 
bonds, the MPBA’s C-ring mode at 1071 cm-1 (Figure 3e) 
becomes suppressed while the weakly active C-ring mode at 
1098 cm-1 (Figure 3f) changes its vibrational geometry to highly 
active “constrained-bending” and shifts its peak location to 
1084 cm-1 (Figure 1b). As a result, the position of the hybridized 
peak between 1071 and 1084 cm-1 shifts as a function of the 
glucose concentration, and using this approach, we measured 
glucose from 0.1 to 30 mM and demonstrated in ex vivo rabbit-
eye measurements an accuracy within ±0.5 mM of readings 
obtained using a commercial glucose sensor.
To our knowledge, Raman-peak shifting has previously been 
utilized for several sensing applications,42-46 yet tracking a 
Raman-peak shift that results from Raman-mode constraining 
has not been used for glucose sensing. And, tracking the SERS-
peak shift proves to be a more reliable and consistent method to 
measure glucose concentrations than intensity-based SERS-
sensing approaches.44 SERS-emission intensity is directly 
influenced by the enhancement factors of SERS substrates that 
typically show large spatial and chip-to-chip fluctuations, 
whereas the positions of the Raman-emission peaks are 
determined by the vibrational states of the molecules and highly 
independent of the enhancing performance of individual 
substrates.46 Moreover, boronic acid is a biocompatible 
molecule,47-49 and its covalent bonding with glucose is rapid and 
also reversible,50,51 making our approach potentially promising 
for in vivo continuous sensing applications.
RESULTS AND DISCUSSION
For SERS-substrate fabrication, we selected a fabrication 
process previously developed for strong Raman enhancement 
and excellent spatial uniformity;52,53 and further engineered the 
process to produce substrates optimized for this glucose-
sensing application, providing excellent broadband SERS 
response over the relevant spectral range from 785 nm (the 
excitation-laser wavelength) to 858 nm (or 1084 cm-1, the target 
glucose-Raman emission).28 The fabrication was performed in 
a two-step process: (1) hydrothermal synthesis of ZnO 
nanowires (NWs) (Figure 2a); and (2) liquid phase deposition 
of Au nanoparticles (NPs) on the ZnO NWs (Figure 2b).52 The 
ZnO NWs produced in the first step serve as skeletal frames for 
Au-NP deposition, determine the periodicity, width, and height 
of the final Au-NP pillars, and gradually dissolve away during 
the second process step, leaving hollow vertical perforations 
that serve as light passages (Figure 2c, 2d, and S1c). To find an 
optimal geometry of the SERS substrates, we varied the 
concentration of zinc nitrate hexahydrate in the presence of the 
nanowire-growth-limiting hexamethylenetetramine (HMTA) in 
the precursor solution during the first process step, synthesized 
ZnO nanowires of 4 different diameters, 50, 90, 180, and 230 
nm (Figure S1a), and performed the near infrared absorption 
spectroscopy and finite element simulations (Figure 2e-g). The 
results show that the substrates with 50-nm ZnO NWs provide 
almost constant broad absorption (> 85%) over the relevant 
spectral range between 785 and 858 nm, which can be also 
confirmed by the pitch-black appearance of the processed wafer 
(Figure S1d).28,52 The fabricated substrate also exhibited a high 
Raman enhancement factor around 9.31×109 and excellent 
uniformity indicated by the low relative standard deviation 
(RSD) below 4% over 1×1-mm2 area (See Supporting 
Information and Figure S1e, f).52
Using the fabricated substrates, we measured SERS spectra 
of 1 mM MPBA in pure phosphate buffered saline (PBS) 
solution and PBS containing 10 mM glucose (Figure S2a). In 
both cases, two major peaks were observed between 1070-1075 
cm-1 and 1570-1580 cm-1. The former is the “breathing” mode 
assigned to C-S stretching coupled with C-ring expansion, and 
the latter is a mode assigned to B-C stretching coupled with C-
C stretching in-ring.41,54 For the double peak structure between 
1570-1580 cm-1, the low and high frequency peaks correspond 
to MPBA with three and two hydroxyl groups, respectively 
(Figures S2b, c). MPBA naturally has two hydroxyl groups. 
When MPBA is exposed to mildly basic (alkaline) conditions 
(e.g., pH 7.4 PBS solution), the molecule acquires an additional 
hydroxyl group to form (OH-)-MPBA ion, which has been 
reported to have a higher affinity for bonding with glucose.41,55 
Our numerical simulations showed the two forms of MPBA 
behave similarly with regard to the glucose-detection 
mechanism reported in this work, and we considered the three 
hydroxyl groups structure for the following discussions. When 
the MPBA-assembled substrate was immersed in the 10 mM 
glucose solution, the measured peak at 1071.5 cm-1 shifted to 
1072 cm-1 (Figure S2d) due to the changes in the dominant peak 
intensities.
The peak-shifting mechanism can be explained by 
performing a series of numerical simulations of the SERS 
spectra of MPBA with and without bonding glucose (Figure 3). 
MPBA or (OH-)-MPBA attaches to the Au substrate using a 
thiol group (Figure 3a), and glucose bonds on the hydroxyl 
group of MPBA through a dehydration reaction (Figure 3b).  
Two of the three hydroxyl groups of (OH-)-MPBA bond with 
glucose, and the third is left unoccupied. Figures 3c, d show 
SERS spectra of (OH-)-MPBA and glucose-bound (OH-)-
MPBA obtained using density functional theory (DFT) 
simulations. For both MPBA and (OH-)-MPBA without 
glucose, two large peaks were observed at 1071 cm-1 and 1098 
cm-1. The peak at 1071 cm-1 is dominant in this scenario, and 
originates from the coupled C-S stretching and the C-ring 
breathing motions shown in Figure 3e. The peak at 1098 cm-1 is 
assigned to the C-S stretching coupled with the C-ring bending 
motion (shown schematically in Figure 3f). In the case of 
glucose-bonded (OH-)-MPBA, the peak assigned to the C-ring 
“breathing” mode becomes negligible, while the C-ring 
“bending” mode peak becomes dominant and redshifts to 1084 
cm-1, due to the constraint imposed by glucose (Figure 3g). 
Overall, the bonding of glucose shifts the dominant Raman peak 
from 1071 cm-1 toward 1084 cm-1. The molecular structures in 
Figure 3e-g and Supplementary Video 1 show the three motions 
discussed: (1) C-S stretching-coupled C-ring “breathing” mode 
of (OH-)-MPBA, (2) C-S-stretching-coupled C-ring “bending” 
mode of (OH-)-MPBA, and (3) C-S-stretching-coupled C-ring 
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“constrained-bending” mode of (OH-)-MPBA bound with 
glucose.
The theoretical results matched experimental results, 
however the magnitudes of the peak shift in the simulations are 
larger than in the experimental data due to the inherent 
approximations of the DFT method. In the experimental 
measurement environment, unoccupied MPBA molecules are 
expected to co-exist with glucose-bound (OH-)-MPBA 
molecules in the laser-probing spot, and the location of the peak 
will be an average between the unoccupied MPBA molecules 
and glucose-bound (OH-)-MPBA molecules peaks. If the ratio 
of glucose-bound (OH-)-MPBA to unoccupied MPBA 
increases, the peak will shift closer to the theoretical value of 
1084 cm-1.
Glucose bonding can also affect the B-C-stretching-coupled 
C-C stretching mode of MPBA near 1580 cm-1 in a highly acidic 
environment with pH close to 1.40 We have verified, however, 
that this change does not occur in our mildly basic environment 
using 7.4 pH PBS solution (Figure S2e). In addition, we also 
verified that it is difficult to directly observe the SERS peaks of 
glucose molecules. As shown in Figures S2f, g, no peaks were 
observed at the expected locations indicated by the blue arrows 
up to 10 mM glucose.35 Collectively these results supported 
tracking the 1071 cm-1 MPBA’s SERS peak to provide a more 
accurate and reliable method to detect glucose concentrations.
In order to experimentally correlate peak-shift behavior to 
glucose concentration, SERS spectra of MPBA were measured 
in the presence of 0.1-30 mM glucose in PBS. This 
measurement range covers low glucose concentrations found in 
the aqueous humor of healthy adults as well as high 
concentrations observed in diabetic blood samples.56-58 The 
measurements were performed inside the polydimethylsiloxane 
(PDMS) chamber as shown in Figure S3. The plots in Figures 
4a and 4b show the positions of the hybridized SERS peak as a 
function of glucose concentration varying from 0.1 to 30 mM 
in PBS. As discussed earlier, this hybridized peak results from 
MPBA’s C-S-stretching-coupled C-ring “breathing” and 
“bending” modes that are significantly influenced by glucose 
bonding, and are easily observed due to their large combined 
emission intensity. Figure 4a shows SERS spectra of MPBA in 
the presence of glucose concentrations ranging from 0 to 30 
mM. The spectra were normalized with respect to the highest 
peak around 1071.5 cm-1. The initial peak position of MPBA in 
PBS was 1071.5 cm-1, and it shifted toward larger wave 
numbers as the glucose concentration was increased (Figure 
4b). Figure 4c shows the peak position of MPBA 
logarithmically increased with increasing glucose 
concentrations.
Figure 4d shows the initial dynamic response of our peak-
shifting approach when measured in PBS with 0.1, 1, and 10 
mM glucose. We applied additional Savitzky-Golay filter in the 
time domain (See Method and Supporting Information, Figure 
S5). Upon injecting the glucose solution into the measurement 
chamber, the hybridized peak began to shift to the right, and its 
position approached the saturation point over a period. For 
higher glucose concentrations, the peak shifting and saturation 
occurred more rapidly when the concentration reached 10 mM.
The reaction between MPBA and glucose and the 
relationship between the peak wavenumbers follow the first 
order reaction rate equation:49
Eq. 1𝑊𝑛 = 𝑊0 + 𝐴 ∙ (𝑒𝑥𝑝( ― 𝑡 𝜏) ― 1)
where Wn, W0, A, t, and τ represent the peak wavenumber in 
glucose solution, the peak wavenumber in PBS solution, real 
constant, time, and time constant, respectively; as the glucose 
concentration increases, the rate of peak shift increases. We 
formulated an analytical glucose-sensing model to predict the 
device response at various concentrations ranging from 0 - 30 
mM (see Supporting Information and Figure S5 for more 
details).
The standard way to estimate the glucose concentration using 
Raman-mode constraining is to measure the peak shift directly 
after the reaction has reached an equilibrium and the peak 
position has almost finalized. The measurement speed of this 
method requires approximately 10 to 30 minutes depending on 
the glucose concentration (Figure S5 (a-c)). Predicting the 
concentration from the initial slope of the peak shifting is 
accurate and fast, which can be completed within 1 minute. For 
systems that start from a standard baseline or where the initial 
glucose concentration (Cinitial) is known, the slope method can 
be as accurate as the peak position shift, as shown in Figure S5. 
A stand-alone slope method has not been tested for dynamically 
changing environments because it requires pre-knowledge of 
Cinitial to improve the estimation of Cfinal. Extensive comparisons 
between the final peak-shift and initial slope methods as well as 
a combination of these two methods in dynamically changing 
environments will be pursued in the future, building upon the 
work presented in this manuscript. 
Next, we tested our approach for its reversibility and ability 
to track ambient glucose concentrations, important factors for 
continuous monitoring. The weak association constant of 
phenylboronic acid with glucose (4.6 M-1 at pH 7.4)59 is 
advantageous for real-time continuous sensing of 
concentrations of glucose. Glucose molecules maintain a 
dynamic equilibrium between association and disassociation 
with MPBA, allowing continuously changing glucose 
concentrations in solution to be monitored. We performed 
dynamic response testing by placing a MPBA-coated chip in the 
PDMS test chamber and alternating the ambient solution 
between PBS and 10 mM glucose PBS solutions. When the 
glucose solution was injected into the chamber the peak shifted 
to a larger wavenumber, and when the glucose line was turned 
off and the PBS solution line was turned on, the peak returned 
to the initial location. Due to the relatively weak bonding force 
between MPBA and glucose, our approach showed reversible 
peak shifting and continuous monitoring of the glucose 
concentration as shown in Figure S5g.49-51,59
Achieving reliable and stable measurements over an 
extended period is an important criterion for practical 
application of sensors, especially implantable devices. Hence, 
we tested the long-term usability of our approach by measuring 
the SERS-peak locations in a 10 mM glucose PBS solution for 
one month. As shown in Figure S6, the device produced a very 
stable sensing result during the test period. The average daily 
drift of the peak position over this period was -0.0006 cm-1 per 
day, which is highly encouraging for long-term continuous 
glucose monitoring.
Fructose, which has five hydroxyl groups, can also bond with 
MPBA in a similar manner and shift MPBA’s Raman peak.60,61 
However, the concentrations of fructose observed in aqueous 
humor, urine, and blood are typically one-thousandth to one-
hundredth of the glucose concentrations,56,62,63 and thus, its 
influence on our glucose measurement is considered negligible.
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As a feasibility study, we measured glucose concentrations in 
the aqueous humor of fresh ex vivo rabbit eyes using the Raman-
mode constraining approach. Eyes are light-friendly biological 
structures suitable for optical sensing. In addition, we use 
polydimethylsiloxane (PDMS) to fabricate the implant mount 
for our SERS disks. PDMS is a biocompatible material,64,65 and 
has been utilized for the fabrication of implantable medical 
devices as well as ocular implants in the past.66-68 In the ciliary 
body, the aqueous humor is produced by diffusion and 
ultrafiltration of blood plasma through the ciliary body.69 As a 
result, the glucose concentration in the aqueous humor follows 
the blood glucose level more consistently and closely than other 
bodily fluids such as tears.56-58,69,70 The glucose range of 0.1-30 
mM in the aqueous humor corresponds to 0.1-60 mM in blood, 
which covers the physiologically relevant glucose levels 
observed in normal and diabetic conditions.
The anterior chamber of human eyes has emerged as an 
optimal site for compact, minimally-invasive medical implants, 
providing easy optical accessibility for convenient and remote 
monitoring of various aspects of human health.71 For the ex vivo 
measurements, we fabricated C-shaped PDMS implants 
mounted with SERS disks (Figure 5a-c and Experimental 
Procedures in Supporting Information). The C-shaped PDMS, 
measuring 1 mm in arm width, is elastic and flexible, it can be 
folded in half as shown in Figure 5d. This allowed for insertion 
through a small incision in the cornea, and, when released, the 
folded implant self-restored back to its original C shape and 
positions itself inside the anterior chamber as shown in Figure 
5e (Experimental Procedures in Supporting Information and 
Figure S7). We performed the ex vivo eye measurements as 
shown in Figure 5f. The SERS implants were positioned about 
halfway between the center and the edge of the cornea (Figure 
5e), and the optical transmittance of a fresh rabbit cornea is over 
90% between 520 and 870 nm.72 The laser light passes through 
the cornea and reaches the SERS disk placed off the optical axis 
of the eye, mainly exposing the cornea to the laser light. Risk of 
thermally damaging the cornea is minimal because the cornea 
has high transmittance (over 95 % at 785 nm), and the tissues 
show minimum absorption at 785 nm.72 We measured the 
glucose concentrations of the rabbit aqueous humor using the 
SERS implants and compared the values with concurrently 
obtained readouts from a commercially available 
electrochemical glucose sensor with an accuracy of ±15% in 
99% of the measurements for glucose concentration above 4 
mM (Figure 5g). All of the data measured by the implanted 
sensor were located in the region A of the Clarke error grid 
(Figure 5h). Our SERS sensors produced robust Raman peaks 
with high intensity and positions that were easily tracked. Our 
Raman-mode-constraining approach produced measurements 
that matched the readouts concurrently obtained from the 
commercial sensor within 0.5 mM. This error range is 
acceptable for use with diabetic patients73 whose glucose 
concentrations would typically vary on the order of 10 mM.
CONCLUSION
We have investigated Raman-mode constraining of MPBA 
resulting from glucose bonding, identified its underlying 
mechanism in simulation studies, and demonstrated 
quantitative, accurate glucose sensing in an on-chip 
microfluidic environment as well as in ex vivo rabbit eyes. 
Glucose-MPBA bonding modifies two of MPBA’s Raman 
modes, resulting in a peak shift whose magnitude can be 
correlated to the ambient glucose concentration.
Our approach overcomes naturally weak SERS signals of 
glucose, shows good resistance against enhancement variations 
that are inherent to SERS substrates, and it could potentially 
allow monitoring continuously changing glucose 
concentrations at levels observed in the aqueous humor and 
blood. Future studies will focus on developing implantable 
devices with improved Raman enhancement, signal-to-noise 
ratios, and concentration-readout speed to pursue 
measurements in living animals and ultimately in humans. With 
further improvements, these results may open up a path for 
practical SERS-based in vivo glucose sensors.
Page 4 of 14
ACS Paragon Plus Environment
Analytical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Figure 1. Glucose-detection mechanism based on SERS-peak shifting. (a) Schematic illustrations of MPBA (left) and glucose-bound MPBA 
(right). (b) A shift in the dominant Raman peak of MPBA from v1 to v1’ resulting from glucose bonding with MPBA. (c) Schematic illustration 
and SEM of highly uniform surface-enhanced Raman scattering using 3D Au-NP clusters stacked in a vertical pillar arrangement.
Figure 2. Fabrication and properties of the SERS substrate. (a) ZnO NWs fabricated on Si substrate using hydrothermal synthesis. (b) 3D Au 
NP deposited in a pillar array format using the liquid phase deposition. SEM images of (c) ZnO NW template and (d) 3D Au NP clusters. 
(e) Electric field norm (|E|) of 3D stacked Au-NP cluster SERS substrate with various diameters of ZnO NW templates. (f) Experimental 
and (g) simulation results of absorption of the SERS substrates made with ZnO NWs of four different diameters.
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Figure 3. Analysis of SERS-peak shift using numerical simulations based on the density functional theory (DFT). DFT simulation geometries 
used for studying (OH-)-MPBA’s Raman-peak shifting mechanism (a) before glucose bonding and (b) after glucose bonding. (c) DFT-
simulation of (OH-)-MPBA and (OH-)-MPBA-glucose bonded SERS spectra in mildly basic (pH 7.4) PBS. (d) SERS spectra of MPBA 
showing the C-S-stretching-coupled C-ring “breathing” mode at 1071 cm-1, the C-S-stretching-coupled C-ring “bending” mode at 1098 cm-1, 
and the glucose-bound C-S-stretching-coupled C-ring “constrained bending” mode at 1084 cm-1 along with molecular structures indicating 
the vibrational motions. Schematic diagrams showing the in-plane C-ring vibrational modes of (OH-)-MPBA: (e) “breathing” mode at 1071 
cm-1, (f) “bending” mode at 1098 cm-1, and (g) “constrained bending” mode of glucose-bound (OH-)-MPBA at 1084 cm-1.
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Figure 4. Measuring glucose concentrations by tracking Raman-peak positions. (a) Normalized SERS spectra of MPBA in the presence of 
glucose concentrations ranging from 0 to 30 mM. (b) Magnified view of SERS peaks near 1071 cm-1 for glucose concentrations from 0 to 
30 mM. (c) SERS peak position vs. glucose concentration for glucose concentrations between 0 and 30 mM. (d) Initial dynamic shifting of 
SERS peak positions vs. time when 0.1, 1, and 10 mM glucose solutions are applied at t = 0; initial slopes are a function of glucose 
concentration and distinct at each concentration.
Figure 5. Measuring glucose concentrations in the aqueous humor of ex vivo rabbit eyes. (a) A photo of the SERS-disk-mounted C-shaped 
implant made of PDMS; the loop diameter is 10 mm, the circular shaped beam is 1 mm wide, and the mounting region is 1.5 mm wide. (b) 
A photographic image of a SERS disk. (c) A SEM image of 3D-stacked Au NP clusters fabricated on the SERS disk. (d) A photo of the 
folded SERS-disk-mounted implant. (e) A photo of the implant inserted inside the anterior chamber of the ex vivo rabbit eye. (f) Schematic 
illustration of the glucose measurement made using the SERS implant inside the anterior chamber of an ex vivo rabbit eye. (g) Glucose 
concentration measurements made using our Raman-mode constraining approach (blue) in comparison with readouts concurrently obtained 
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constraining served as references to calculate the other four measurements (#3-#6), and the corresponding glucose concentrations are 
displayed in blue over the histograms; (h) A Clarke error grid analysis of the glucose measurements using our Raman-mode constraining 
approach in ex vivo rabbit eyes.
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 Figure 1. Glucose-detection mechanism based on SERS-peak shifting. (a) Schematic illustrations of MPBA 
(left) and glucose-bound MPBA (right). (b) A shift in the dominant Raman peak of MPBA from v1 to v1’ 
resulting from glucose bonding with MPBA. (c) Schematic illustration and SEM of highly uniform surface-
enhanced Raman scattering using 3D Au-NP clusters stacked in a vertical pillar arrangement. 
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 Figure 2. Fabrication and properties of the SERS substrate. (a) ZnO NWs fabricated on Si substrate using 
hydrothermal synthesis. (b) 3D Au NP deposited in a pillar array format using the liquid phase deposition. 
SEM images of (c) ZnO NW template and (d) 3D Au NP clusters. (e) Electric field norm (|E|) of 3D stacked 
Au-NP cluster SERS substrate with various diameters of ZnO NW templates. (f) Experimental and (g) 
simulation results of absorption of the SERS substrates made with ZnO NWs of four different diameters. 
178x127mm (300 x 300 DPI) 
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 Figure 3. Analysis of SERS-peak shift using numerical simulations based on the density functional theory 
(DFT). DFT simulation geometries used for studying (OH-)-MPBA’s Raman-peak shifting mechanism (a) 
before glucose bonding and (b) after glucose bonding. (c) DFT-simulation of (OH-)-MPBA and (OH-)-MPBA-
glucose bonded SERS spectra in mildly basic (pH 7.4) PBS. (d) SERS spectra of MPBA showing the C-S-
stretching-coupled C-ring “breathing” mode at 1071 cm-1, the C-S-stretching-coupled C-ring “bending” 
mode at 1098 cm-1, and the glucose-bound C-S-stretching-coupled C-ring “constrained bending” mode at 
1084 cm-1 along with molecular structures indicating the vibrational motions. Schematic diagrams showing 
the in-plane C-ring vibrational modes of (OH-)-MPBA: (e) “breathing” mode at 1071 cm-1, (f) “bending” 
mode at 1098 cm-1, and (g) “constrained bending” mode of glucose-bound (OH-)-MPBA at 1084 cm-1. 
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 Figure 4. Measuring glucose concentrations by tracking Raman-peak positions. (a) Normalized SERS spectra 
of MPBA in the presence of glucose concentrations ranging from 0 to 30 mM. (b) Magnified view of SERS 
peaks near 1071 cm-1 for glucose concentrations from 0 to 30 mM. (c) SERS peak position vs. glucose 
concentration for glucose concentrations between 0 and 30 mM. (d) Initial dynamic shifting of SERS peak 
positions vs. time when 0.1, 1, and 10 mM glucose solutions are applied at t = 0; initial slopes are a 
function of glucose concentration and distinct at each concentration. 
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 Figure 5. Measuring glucose concentrations in the aqueous humor of ex vivo rabbit eyes. (a) A photo of the 
SERS-disk-mounted C-shaped implant made of PDMS; the loop diameter is 10 mm, the circular shaped 
beam is 1 mm wide, and the mounting region is 1.5 mm wide. (b) A photographic image of a SERS disk. (c) 
A SEM image of 3D-stacked Au NP clusters fabricated on the SERS disk. (d) A photo of the folded SERS-
disk-mounted implant. (e) A photo of the implant inserted inside the anterior chamber of the ex vivo rabbit 
eye. (f) Schematic illustration of the glucose measurement made using the SERS implant inside the anterior 
chamber of an ex vivo rabbit eye. (g) Glucose concentration measurements made using our Raman-mode 
constraining approach (blue) in comparison with readouts concurrently obtained using a commercial 
electrochemical glucose sensor (red). The first two measurements (#1 and #2, blue) made using Raman-
mode constraining served as references to calculate the other four measurements (#3-#6), and the 
corresponding glucose concentrations are displayed in blue over the histograms; (h) A Clarke error grid 
analysis of the glucose measurements using our Raman-mode constraining approach in ex vivo rabbit eyes. 
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